Completed PHASE2/PHASE3 INTERVENTIONAL 2-arm NCT05160493

The Effect of Esketamine Combined With Pregabalin on Chronic Postsurgical Pain in Patients After Craniotomy.

Sponsor: Beijing Tiantan Hospital

Interventions Normal saline and placebo capsule S-ketamine and pregabalin

Updated 6 times since 2022 Last updated: Jul 30, 2024 Started: Dec 20, 2021 Primary completion: Dec 11, 2023 Completion: Jun 20, 2024

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2/PHASE3 clinical study on Chronic Postsurgical Pain, this trial is completed. The trial is conducted by Beijing Tiantan Hospital and has accumulated 6 data snapshots since 2021. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2/PHASE3
Aug 2024 — Sep 2024 [monthly]

Completed PHASE2/PHASE3

Status: Unknown → Completed
Jul 2024 — Aug 2024 [monthly]

Unknown PHASE2/PHASE3

Status: Unknown Status → Unknown · Phase: PHASE2_PHASE3 → PHASE2/PHASE3
Jun 2024 — Jul 2024 [monthly]

Unknown Status PHASE2_PHASE3

Status: Recruiting → Unknown Status
Jun 2022 — Jun 2024 [monthly]

Recruiting PHASE2_PHASE3

Status: Not Yet Recruiting → Recruiting

▶ Show 1 earlier version

Jan 2022 — Jun 2022 [monthly]

Not Yet Recruiting PHASE2_PHASE3

First recorded

Dec 2021

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Beijing Tiantan Hospital

Data source: Beijing Tiantan Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Beijing, China